Molecular and Cellular Biochemistry

, Volume 156, Issue 2, pp 173–178 | Cite as

Muscle ubiquinone in male effort angina patients

  • Jan Karlsson
  • Lijun Lin
  • Sigurd Gunnes
  • Christer Sylvén
  • Hans Åström
Article

Abstract

Seven (7) males with effort angina and listed for coronary by-pass surgery had muscle biopsies taken from their vastus lateralis muscle for determination of muscle fiber types (%ST), ubiquinone (vitamin Q, UQ), oxidative and fermentative enzyme activities. Graded cycle ergometer exercise to determine intensities corresponding to onset of blood lactate accumulation set to 2.0 nimol × 1−1 (WOSLA) and symptom limited exercise (‘maximal’, WSL) were also undertaken. WOBLA was positively related to %ST (r = 0.92, p < 0.001). %ST was on the other hand inversely related to UQ (r =−0.82, p < 0.05), the heart specific LD subunit LD-H (r =−0.96, p < 0.001), the isozyme LD3 as the fraction of LD (%LD3) (r=−0.93, p < 0.01), and the CK isozyme CKMB as the fraction of CK (%CKMB) (r = −0.88, p < 0.05). It was suggested that muscle UQ depletion in the patients was related to molecular oxygen and free oxygen radical formation. The lack of antioxidants then caused a radical trauma specifically to the ST fiber and their mitochondria. This could be a cause and-effect explanation for the selective ST fiber downregulation in effort angina and heart failure in general.

Key words

effort angina antioxidant vitamins ubiquinone vitamin Q muscle fiber types muscle oxidative capacity oxygen availability exercise capacity muscle fiber trauma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Just H, Drexler H, Zelis R: A symposium: regional blood flow in congestive heart failure. Am J Cardiol (suppl E) 62: 1–114, 1988Google Scholar
  2. 2.
    LeJemtel TH, Scortichini D, Katz S: Direct and indirect assessment of skeletal muscle blood flow in chronic congestive heart failure. Am J Cardiol (Suppl E) 62: 36–39, 1988Google Scholar
  3. 3.
    Wiener DH, Fink LL Maris J, Jones RA, Chance B, Wilson JR: Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 73: 1127–1136, 1986Google Scholar
  4. 4.
    Massie B, Canway M, Yonge R, et al: Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 76: 1009–1019, 1987Google Scholar
  5. 5.
    Andersen P: Capillary density in skeletal muscle of man. Acta Physiol Scand 95: 203–205, 1975Google Scholar
  6. 6.
    Braunwald E, Kloner R: Myocardial reperfusion: A double-edged sword? J Clin Invest 76: 1713–1719, 1985Google Scholar
  7. 7.
    Carlens P, Hindemarsh T, Holmgren A: Left ventricular pump function in effort angina. Eur J Cardiol 10: 475–491, 1979Google Scholar
  8. 8.
    Braumwald E: Control of myocardial oxygen consumption. Am J Cardiol 27: 416–432, 1971Google Scholar
  9. 9.
    Karlsson J: Onset of blood lactate accumulation, exercise capacity, skeletal muscle fibers and metabolism before and after coronary bypass grafting. Am J Cardiol (suppl E) 62: 108–114, 1988Google Scholar
  10. 10.
    Karlsson J: Exercise capacity and muscle fibre types in effort angina. Eur Heart J (suppl G) 8: 51–57, 1987Google Scholar
  11. 11.
    Karlsson J: Localized muscular fatigue: role of muscle metabolism and substrate depletion. In: R.S. Hutton, D.I. Miller (ed.). Exercise and Sports Sciences Review. Franklin Institute Press, Philadelphia, 1979, pp 1–42Google Scholar
  12. 12.
    Winrow WR, Wimyard PG, J. MC, Blake DR: Free radicals in inflammation: second messsengers and mediators in tissue distruction. Br Med Bull 49: 506–522, 1993Google Scholar
  13. 13.
    Laurent C, Johnson-Wells G, Hellström S, Engström-Laurent A, Wells A: Localization of hyaluxonan in various muscular tissues: a morphological study in the rat. Cell Tissue Res 263: 201–205, 1991Google Scholar
  14. 14.
    Luft R: The development of mitochondrial medicine. Proc Natl Acad Sci 91: 8731–8738, 1994Google Scholar
  15. 15.
    Kanter MM: Free radicals, exercise and antioxidant supplementation. IJSN 4: 205–220, 1994Google Scholar
  16. 16.
    Pincemail J, Deby C, Dethier A: Pentane measurements in man as an index of lipoperoxidation. Bioelectrochem Bioenerg 18: 117–125, 1987Google Scholar
  17. 17.
    Inoe T, Mu Z, Sumikawa K, Adachi K, Okochi T: Effect of physical exercise on the content of 8-hydroxydeoxyguanosine in nuclear DNA prepared from lymphocytes. Jpn J Cancer Res 84: 720–725, 1993Google Scholar
  18. 18.
    GEIGY: Constituents of living matters — Vitamins. In: C. Lentner (ed.). Geigy Scientific Tables. Basle: CIBA-GEIGY Limited, 1986, pp 61–70Google Scholar
  19. 19.
    Ernster L, Forsmark P, Nordenbrand K: The mode of action of lipidsoluble antioxidants in biological membranes: relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. BioFactors 3: 241–248, 1992Google Scholar
  20. 20.
    Karlsson J: Heart and skeletal muscle ubiquinone or CoQ10 as a protective agent against radical formation in man. In: G. Benzi (ed.). Advances in Myochemistry. London: John Libbey, 1987, pp 305–318Google Scholar
  21. 21.
    Beyer RE, Nordenbrand K, Emster L: The role of coenzyme Q as a mitochondrial antioxidant: a short review. In: K. Folkers, Y. Yamamura (ed.). Biomedical and clinical aspects of coenzyme Q. Amsterdam: Elsevier, 1986, pp 17–24Google Scholar
  22. 22.
    Diplock AT: Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr (Suppl) 53: 189–193, 1991Google Scholar
  23. 23.
    Karlsson J: Muscle exercise, energy metabolism and blood lactate. In: L. Tavazzi, P.E. di Prampero (ed.). The Anaerobic Threshold. Physiological and Clinical Significance. Basel: Karger, 1986, pp 35–46Google Scholar
  24. 24.
    Bergström J: Muscle electrolytes in man. Acta Physiol Scand Suppl. 68: 1–87, 1962Google Scholar
  25. 25.
    Padykula HA, Herman E: The specificity of the histochemical method for adenosine triphosphate. J Histochem Cytochem 3: 170–183, 1955Google Scholar
  26. 26.
    Tesch P: Muscle fatigue in man. Acta Physiol Scand (Suppl) 480: 140, 1980Google Scholar
  27. 27.
    Vadhanavikit S, Morishita M, Duff GA, Folkers K: Micro-analyses for coenzyme Q10 in endomyocardial biopsies of cardiac patients and data on bovine and canine hearts. Biochem Biophys Res Commun 123: 1165–1169, 1984Google Scholar
  28. 28.
    Shepherd D, Garland P: Citrate synthase from rat liver. Meth Enzymol 13: 11–16, 1969Google Scholar
  29. 29.
    SSCCCP, Physiology TSSfCCaC: Recommended method for the determination of four enzymes in blood. Scand J Clin Invest 36: 711–723, 1974Google Scholar
  30. 30.
    Sylven C, Jansson E, Kallner A, B66k K: Human creatine kinase. Scand J Clin Lab Invest 44: 611–615, 1984Google Scholar
  31. 31.
    Karlsson J, Sjödin B, Thorstensson A, Hultén B, Frith K: LDH isozymes in skeletal muscle of endurance and strength trained subjects. Acta Physiol Scand 93: 150–156, 1975Google Scholar
  32. 32.
    Rosalki SB: Standardization of isoenzyme assays with special reference to lactate dehydrogenase isoenzyme electrophoresis. Clin Biochem 7: 29–40, 1974Google Scholar
  33. 33.
    Lin L, Sylven C, Sotonyi P, Somogyi E, Kaijser L, Jansson E: Lactate dehydrogenase and its isoenzyme activities in different parts of the normal heart. Cardiovasc Res 23: 601–606, 1989Google Scholar
  34. 34.
    Thorstensson A, Sjödin B, Karlsson J: Separation of isozymes of creatine phosphokinase and lactate dehydrogenase in human heart muscle by isoelectric focusing. In: P.G. Righetti (ed.). Progress in Isoelectric Focusing and Isotachophoresis. Amsterdam: North-Holland Publishing Company, 601–607, 1975Google Scholar
  35. 35.
    Mercer DW. Separation of tissue and serum creatine kinase isoenzymes by ion-exchange chromatography. Clin Chem 20: 36–40, 1974Google Scholar
  36. 36.
    Jansson E, Sylven C: Creatine kinase MB and citrate synthase in type I and II muscle fibres in trained and untrained men. Eur J Appl Physiol 54: 207–209, 1985Google Scholar
  37. 37.
    Karlsson J, Lin L, Jansson E, Sylven C: Muscle ubiquinone in healthy physically active males. Mol Cell Biochem 156: 169–172, 1996Google Scholar
  38. 38.
    Larsson L: Morphological and functional characteristics of the ageing skeletal muscle in man. Acta Physiol Scand Suppl. 457: 1–36, 1978Google Scholar
  39. 39.
    Karlsson J, Jacobs I: Onset of blood lactate accumulation during muscular exercise as a threshold concept. Int J Sports Med 3: 190–201, 1982Google Scholar
  40. 40.
    Jenkins RR, Friedland R, Howald H: The relationship of oxygen uptake to superoxide dismutase and catalase activity in humans skeletal muscle. Int J Sports Med 5: 11–14, 1984Google Scholar
  41. 41.
    Poole-Wilson PA, Buller NP, Lipkin DP: Regional blood flow, muscle strength and skeletal muscle histology in severe congestive heart failure. Am J Cardiol (Suppl E) 62: 49–52, 1988Google Scholar
  42. 42.
    Thorstensson A, Tesch P, Sjödin B, Karlsson J: Actomyosin ATPase, myokinase, CPK and LDH in humans fast and slow twitch fibers. Acta Physiol Scand 99: 225–229, 1977Google Scholar
  43. 43.
    Clarkson P, Ebbeling C: Investigation of serum creatine kinase variability after muscle-damaging exerecise. Clin Sci 75: 257–261, 1988Google Scholar
  44. 44.
    Gey FK. Vitamin E and other essential antioxidants regarding coronary heart disease: risk assessment studies. In: L. Packer, J. Fuchs (ed.). Vitamin E in Health and Disease. New York: Marcel Dekker Inc., 589–633, 1993Google Scholar
  45. 45.
    Littarru GP, Ho L, Folkers K: Deficiency of coenzyme Q 10 in human heart disease I. Int J Vit Nut Res 42: 291–297, 1972Google Scholar
  46. 46.
    Karlsson J, Diamant B, Theorell H, Johansen K, Folkers K. Plasma alpha-tocopherol and ubiquinone and their relations to muscle function in healthy human and in cardiac diseases. In: L. Packer, J. Fuchs (ed.). Vitamin E: Biochemistry and Clinical Applications. New York: Marcel Dekker, Inc, 473–493, 1993Google Scholar
  47. 47.
    Gey KF, Puska P, Jordan P, Moser UK: Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in crosscultural epidemiology. Am J Clin Nutr (Suppl) 53: 326–143, 1991Google Scholar
  48. 48.
    Demopoulos HB, Santomier JP, Seligman ML, Pietronigro L: Free radical pathology: rationale and toxicology of antioxidants and other supplements in sports medicine and exercise science. In: F.I. Katch (ed.). Sport Health and Nutrition. Champaign, Ill.: Human Kinetics Publishers Inc., 139–189, 1984Google Scholar
  49. 49.
    Sawyer DT: 02! Who would have imagined all the biological processes that involve oxygen? CHEMTECH; (June): 369–375, 1988Google Scholar
  50. 50.
    Karlsson J: The antioxidant strategy and exercise. Champaign, IL: Human Kinetics Publishers, Inc, 1996, In printGoogle Scholar
  51. 51.
    Liu KZ, Cuddy TE, Pierce GN: Oxidative status of lipoproteins in coronary disease patients. Am Heart J 123: 285–290, 1992Google Scholar
  52. 52.
    Brown MS, Goldstein JL: Lipoprotein receptors: therapeutic implications. J Hypertens (Suppl 1) 8: 33–36, 1990Google Scholar
  53. 53.
    Princen HM, Poppel van G, Vogelesang C, Buytenhek R, Kok FJ: Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of smoking. Arterioscler Thromb 12: 554–562, 1992Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Jan Karlsson
    • 5
  • Lijun Lin
    • 1
  • Sigurd Gunnes
    • 2
  • Christer Sylvén
    • 3
  • Hans Åström
    • 4
  1. 1.Department of Clinical PhysiologyKarolinska InstituteSweden
  2. 2.Department of Thoracic Surgery Karolinska InstituteSweden
  3. 3.Department of Cardiology, Huddinge University HospitalKarolinska InstituteSweden
  4. 4.Department of Thoracic Clinical PhysiologyKarolinska InstituteSweden
  5. 5.OBLA ABVaxholmSweden

Personalised recommendations